News items Radboud university medical center accelerates medical imaging innovation with AWS Cloud
23 November 2021

Radboud university medical center in partnership with Amazon (NASDAQ: AMZN) announce the launch of on AWS, a machine learning platform that accelerates innovation in the field of medical imaging by leveraging AWS Cloud solutions. The open-science platform allows builders from around the world to share sensitive medical images securely, collaborate globally on research projects, and build, benchmark, and deploy ML models to solve the hardest problems in the industry.

Despite billions spent globally every year on healthcare research and innovation, building AI/ML solutions for medical imaging remains a difficult and expensive undertaking. Researchers need access to high performance clusters of GPUs to run ML training jobs as well as large volumes of high-quality datasets, labeled and validated by experts. They also need to build, configure, and maintain complex AI/ML pipelines for training, tuning, debugging, and deployment.

Established by Radboud university medical center in 2010, allows researchers and clinicians to leverage AI/ML technologies, reducing costs, supporting collaboration, and accelerating innovation. With a sharp increase in demand for access to the platform during the COVID-19 pandemic, in March of 2020 Prof. Bram van Ginneken’s team at Radboud university medical center turned to AWS to migrate to the AWS cloud as well as expand the scope and scale of the platform. This partnership opened up new opportunities to accelerate the global medical imaging research community and today the platform has grown to over 64,000 registered users from across the world.

Since its inception,, has empowered medical teams and academic centers to reinvent their medical imaging research. Any research and development organization or consortium can organize medical imaging projects by publishing their research projects on Participants from around the world gain access to curated data, tools to visualize and pre-process images, and end-to-end ML pipelines in one place, accessible from any location, through the convenience of a web browser. In addition, the global research community now has access to publicly available collection of AI/ML algorithms as well as medical image datasets made available at and Registry of Open Data on AWS, respectively.

“Migrating to the AWS Cloud has allowed us to provide an integrated and scalable solution where medical researchers and data scientists can work together to build and validate AI/ML models,” said Prof. Bram van Ginneken of Radboud university medical center. “The AWS cloud can accelerate our research, and will allow us to bring potentially life-saving new image analysis algorithms to our healthcare systems.”

“We are delighted to be working with Radboud university medical center and to accelerate research in medical imaging,” said Razvan Ionasec, Technical Leader for Healthcare in Europe, Middle East, and Africa for Amazon Web Services. “ on AWS will provide the technical and organizational framework required to allow builders and clinicians to innovate faster and collaborate more effectively to solve healthcare’s most difficult challenges.”

Since its launch, academic medical research centers have teamed up with to improve patient outcomes. Projects have included pathology diagnostics for prostate cancer, brain MRI lesion detection, lung cancer detection in chest radiographs and chest CT scans at institutions such as the Karolinska Institute, Amsterdam UMC, University College London, King’s College London, the National Institute of Health, Fraunhofer MEVIS, Vancouver General Hospital, and the Memorial Sloan Kettering Cancer Center.

To learn more visit:

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

Dutch-Nordic Alliance for Precision Cancer Medicine launched

26 November 2021

The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.

read more

Last chance - Call for nominations Supervisor of the Year & Image award

25 November 2021

The RIMLS PhD Council has extended the deadline to 1 December to nominate supervisors and images for the supervisor of the year and image awards. Send in your nominations while you still can!

read more

The effects of dopamine levels on reward responsivity

25 November 2021

To adapt to the ever-changing context in which we live, we are constantly deciding how much effort to put into performing our behavior, or how fast to perform our actions. How do people decide how fast to act and how does the brain compute this? Our researchers set out to investigate this.

read more

Academic collaboration agreement between UTwente and Radboudumc

23 November 2021

The group of Biomaterials Science and Technology (BST) of the Faculty of Science and Technology at the TechMed centre of University of Twente has signed a formal academic collaboration agreement with the departments of Nephrology and Physiology at Radboudumc.

read more

New anti-inflammatory drugs increase risk of fungal infection

22 November 2021

Investigators at the Department of Internal Medicine / Infectious Diseases and Dermatology demonstrate worldwide side effects of certain so-called biologics using four different research approaches

read more